Hall A |
Hall B |
Hall C |
Hall D |
08:30-10:30 |
|
Opening Plenary Session: Setting the scene – Definitions and epidemiology |
10:30-11:00 Coffee Break, Poster and Exhibition Visit |
11:00-12:30 |
11:00-12:30 |
11:00-12:30 |
11:00-12:30 |
Parallel Session: Global risks and consequences of 'prediabetes2007/MetS |
Parallel Session: Physiologic
abnormalities associated with the MetS |
Parallel Session: Role of the Liver in Insulin Resistance and the MetS: NAFLD |
Free Communications:
Therapy
|
12:30-14:00 Lunch Break, Poster and Exhibition Visit |
14:00-15:30 |
14:00-15:30 |
14:00-15:30 |
14:00-15:30 |
Parallel Session: Aging and the MetS, Prediabetes and Diabetes |
Parallel Session: Mitochondrial
mechanisms and the MetS,
Prediabetes and DM |
Parallel Session: Cerebral manifestations of the MetS |
Free Communications:
Epidemiology and screening
|
15:30-16:00 Coffee Break, Poster and Exhibition Visit |
16:00-18:00 |
|
Plenary Session: Emerging metabolic therapies |
18:15-20:15 |
18:15-20:15 |
|
|
Satellite Symposium sponsored by GlaxoSmithKline |
Satellite Symposium sponsored by MSD |
|
|
Friday, April 27, 2007
|
Hall A |
Hall B
|
Hall C |
Hall D |
08:30-10:30 |
|
Plenary Session: Hyperglycemia and Heart Disease |
10:30-11:00 Coffee Break, Poster and Exhibition Visit |
11:00-12:30 |
11:00-12:30 |
11:00-12:30 |
11:00-12:30 |
Parallel Session: Prediction of risk and prevention of CVD |
Parallel Session: Cellular
mechanisms and the MetS,
Prediabetes and DM |
Parallel Session: Abdominal Obesity |
Free Communications:
Adipokines and inflammatory/stress markers
|
12:30-14:00 Lunch Break, Poster and Exhibition Visit |
14:00-15:30 |
14:00-15:30 |
14:00-15:30 |
14:00-15:30 |
Parallel Session: Vascular effects of Gluco-metabolic therapies |
Parallel Session:
The Metabolic
Syndrome and the Myocardium |
Parallel Session: Emerging new treatments of Obesity |
Free Communications:
Genetics
|
15:30-16:00 Coffee Break, Poster and Exhibition Visit |
16:00-18:00 |
|
Plenary Session: Preventing DM with Gluco-metabolic Interventions in people with dysglycemia – The evidence |
|
18:15-20:15 |
18:15-20:15 |
|
|
Satellite Symposium sponsored by Eli Lilly |
Satellite Symposium sponsored by Novartis |
|
Saturday, April 28, 2007
|
Hall A |
Hall B |
Hall C |
Hall D |
08:30-10:00 |
08:30-10:00 |
08:30-10:00 |
08:30-10:00 |
Parallel Session: Do Gluco-metabolic Interventions prevent CVD? |
Parallel Session: Nutrition and the MetS |
Parallel Session:
prediabetes2007/MetS in the young |
Free Communications:
Heart and vascular |
10:00-10:30 Coffee Break and Exhibition Visit |
10:30-12:00 |
10:30-12:00 |
10:30-12:00 |
10:30-12:00 |
Parallel Session: Does targeting
treatment to individual
components of the MetS
reduce CVD?
|
Parallel Session: Implication of
LDL cholesterol in people with dysglycemia
|
Parallel Session: Life-cycle determinants of obesity, diabetes and CVD |
Free Communications:
Mechanism of disease- insulin resistance and prediabetes
|
12:00-12:15 |
|
| Prize Award Session |
12:15-13:45 |
Plenary Session:
Partners in Prevention |
14:00 Farewell Reception |
|
